Vascular malformations and PIK3CA-related Overgrouwht Spectrum
Conditions
Interventions
None listed
Sponsors
ARTham Therapeutics Inc
National Center for Child Health and Development Shinshu University Osaka University Oita University Keio University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Vascular malformations, PROS (PIK3CA-related overgrowth spectrum)
Exclusion criteria
Exclusion criteria: Other vascular malformations (lymphedema, HHT or familial vascular malformations) Known history of HBV, HCV, HTLV and HIV infection Patient who is judged inappropriate to participate in this study by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A pathogenic mosaic mutations analysis of the Japanese patients with vascular malformations and PROS(PIK3CA-related overgrowth Spectrum) | — |
Countries
Japan
Contacts
Public ContactMichio Ozeki
Gifu University Medical department
Outcome results
None listed